Clinical Lab Chat

In this episode of Clinical Lab Chat, CLP Director of Business Intelligence Chris Wolski discusses the critical role diagnostics play in successful organ transplantation with Tina Liedtky, president of Transplant Diagnostics for Thermo Fisher. During the course of the lively conversation, they discuss:  How diagnostics fit into the organ transplant process. How diagnostics are helping to up the od...

Keywords Cervical Cancer, ASCCP Guidelines, HPV Testing, Self-Collection, At-Home Testing, Women's Health, Diagnostic Solutions, Preventive Care, Medical Technology, Health Access Summary In this episode of Clinical Lab Chat, Chris Wolski and Dr. Jeff Andrews discuss significant advancements in cervical cancer prevention, focusing on the new ASCCP guidelines, the role of technology in screening, a...

In this episode of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, discusses the how and why of making precise clinical diagnosis of neurodegenerative diseases with Russ Lebovitz, MD, PhD, co-founder and CEO of Amprion.   Among the topics they discuss: The critical importance of making accurate diagnoses of neurodegenerative diseases Why alpha-synuclein is an accurate bio...

In this episode of Clinical Lab Chat, CLP Director of Business Intelligence Chris Wolski engages in a wide-ranging discussion with Peggy Lillis Foundation CEO and founder Christian Lillis about the organization’s efforts to raise awareness of C diff. Among the topics they discuss:   Why C diff is difficult to diagnose How Peggy Lillis is engaging with the public, scientific community, and legislat...

In this episode of Clinical Lab Chat, Jeff Andrews, MD, FRCSC, BD’s VP of Global Medical Affairs for Diagnostic Solutions, makes a return visit to the studio for a conversation with CLP’s director of business intelligence, Chris Wolski, about BD and MD Anderson’s collaboration on HPV sample self-collection study.    Among the topics they cover: How self-collection aids in the fight against cervica...

In this episode of Clinical Lab Chat, Director of Business Intelligence Chris Wolski interviews Jeff Andrews, MD, FRCSC, a board-certified gynecologist and vice president of Global Medical Affairs for Diagnostic Solutions at BD, what HPV sample self-collection means for the diagnosis, prevention, and treatment of HPV and cervical cancer.   Among the topics they cover in this wide-ranging interview...

In this edition of Clinical Lab Chat, Director of Business Intelligence Chris Wolski discusses with Courtney Noah, PhD, VP of Scientific Affairs at BioIVT, how blood-based biofluid testing is poised to revolutionize cancer diagnostics. Among the topics they dig into are: The benefits of blood-based biofluid testing over traditional, more invasive methods. How biofluid testing saves money and impro...

In this episode of Clinical Lab Chat, CLP’s director of business intelligence, Chris Wolski, discusses how point-of-care testing improves access to both diagnostics and treatment with Seth Egan, co-founder of and chief commercialization officer for Co-Diagnostics .   Among the topics they cover in their wide-ranging conversation: How and why point-of-care testing improves both diagnostic and treat...

In this edition of Clinical Lab Chat, CLP’s director of business intelligence, Chris Wolski, interviews Nathan Montgomery, MD, PhD, vice president of medical services at NeoGenomics , about how AI will transform laboratory practices including: The role AI plays in eliminating mundane tasks in the lab, making workflows more efficient. The best practices to follow when implementing AI in your clinic...

In this edition of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, interviews Alessio Travaglia, PhD, PMP, director, Translational Science, Neuroscience, at the Foundation for the National Institutes of Health (FNIH).   The wide-ranging interview tackles all aspects of Alzheimer’s testing and treatment, including: Why traditional methods of Alzheimer’s testing are expensi...

In this wide-ranging episode of Clinical Lab Chat, CLP’s director of business intelligence, Chris Wolski, discusses the hows and whys of keeping kids engaged in science with Natalie Kuldell, executive director of BioBuilder (biobuilder.org), a 501c3 non-profit designed to inspire kids and help teachers and professionals keep students interested in science in school and beyond. Kuldell, who was nam...

In this episode of Clinical Lab Chat, Director of Business Intelligence Chris Wolski presents Jeremy Stackawitz, CEO of Senzo, a challenge—is it possible to create a “perfect” diagnostic test? Using the WHO’s A.S.S.U.R.E.D. criteria, Stackawitz discusses: The operating premise of the criteria How testing is evolving to provide more point-of-care options How Senzo is using the A.S.S.U.R.E.D. criter...

In a shift from talking about clinical diagnostics, this episode of Clinical Lab Chat focuses on how laboratory listeners can manage stress. With the help of Brent Franson, founder and CEO of Most Days, CLP’s director of business intelligence, Chris Wolski, discusses ways you can manage stress, including: Making the “little things”: sleep, exercise, and diet good habits. Why taking a hard look at...

After being declared eradicated in the U.S. in 2000, measles has been making a comeback in recent years—the current caseload equals the entire number of cases in 2023. In this wide-ranging discussion, CLP’s director of business intelligence, Chris Wolski, and Rodney Rohde, PhD, Regents’ Professor in the Texas State University System, a University Distinguished Professor and Chair for the Medical L...

In this episode of Clinical Lab Chat, CLP’s director of business intelligence, Chris Wolski, sits down with OpentronsCEO Jonathan Brennan-Badal to discuss all things robotic. In their wide-ranging discussion, they touch on: The trends in clinical laboratory robots How to make a use case for adding robots to your lab How to plan for automation The challenges with laboratory robotics What to expect...

In this episode of Clinical Lab Chat, CLP Director of Business Intelligence Chris Wolski interviews BD’s Bridget Bagnato about the company’s new MiniDraw technology, and how it is delivering on the promise of Theranos’ failed technology, what it means for access, and how it could be a major paradigm shift in the way patients’ blood specimens are collected and the form in which labs receive them. 

In the latest edition of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, interviews Sara Naseri, MD, co-founder and CEO of women’s health company, Qvin (qvin.com), about the Q-Pad, an FDA-cleared menstrual pad designed to collect blood to be processed for diagnostic purposes. In this wide-ranging discussion, Naseri and Wolski discuss how she came up with this unique, out-...

In this episode of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, engaged in a deep-dive discussion on the burgeoning synergy between omics technologies and precision medicine solutions with Rosy Lee, VP and general manager, Life Sciences Mass Spectrometry, Thermo Fisher Scientific.    Some ideas the two discussed during their conversation include: The significance of pe...

In this episode of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, spoke with Judit Giró Benet, co-founder and CEO of The Blue Box, for an in-depth discussion on breast cancer diagnostics, with a focus on non-invasive testing. Topics touched on during their conversation include: Using urine to identify breast cancer biomarkers The distinctions between mammographies and li...

In this episode of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, interviews Jessica Murphy , MLS(ASCP)CM , senior technical laboratory educator for Thermo Fisher Scientific. Among the topics they tackled: Why there has been an increased prevalence of food allergies among the U.S. population in the past few decades. How home testing has helped to revolutionize allergy id...

In this episode of Clinical Lab Chat, Chris Wolski, CLP’s director of Business Intelligence, David West, CEO of Proscia, and Lou Welebob, vice president and general manager of pathology at Agilent, take a deep dive into the big challenges facing clinical labs today, including workforce shortages, scaling lab operations, and reimbursement, along with some of their solutions, including increased aut...

In the latest episode of Clinical Lab Chat, CLP’s director of business intelligence, Chris Wolski, has a wide-ranging discussion with Jeff Andrews, MD, FRCSC, vice president of Medical Affairs for BD, about BD’s recent STI health survey and what the findings mean for women’s health and their access to care. They also discuss the poor state of medical health education in the U.S., solutions that ca...

In this episode of Clinical Lab Chat, Chris Wolski and his guest, medical lead at Hurdle, Alex Owens, MD, MPH, discuss the reasons for the rise of at-home testing during COVID, how at-home test improves healthcare access, and the win-win-win it brings to clinical laboratories.

In this episode of Clinical Lab Chat, Chris Wolski meets the Texas A&M team behind what could be an effective, highly sensitive test for Lyme disease. Artem Rogovskky, PhD, ACVM, and Dmitry Kurouski, PhD, outline why Lyme disease is a diagnostic challenge and their work on developing a Lyme disease test using Raman spectroscopy.

During the latest installment of Clinical Lab Chat, CLP Director of Business Intelligence Chris Wolski and Prasanth Perugupalli, chief product officer for Pramana, tackle why there have been delays in pathology labs adopting digital solutions, the business case for digital pathology, how it can change laboratory workflows, and what the future holds for digital pathology.